Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.040009 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Ahmed I Soliman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Environmental Health University at Buffalo-SUNY Buffalo NY USA. Hauptthemen laut MEDLINE: Blood Pressure, Hypertension, Menopause, Proton Pump Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, WHI NIH HHS.
Abstract (Originalsprache)
Background
Proton pump inhibitors (PPIs) could affect blood pressure regulation by suppressing gastric acid required for the conversion of oral nitrite into nitric oxide. Whether PPI use is associated with incident hypertension remains unknown.
Methods
We included 64 720 menopausal women who were free from cardiovascular disease and hypertension at enrollment in the Women's Health Initiative Observational Study (1993–1998). Baseline PPI use and duration were determined using medication inventories. The outcome was physician diagnosed/treated incident hypertension, assessed by self‐report on annual questionnaires. Hazard ratios (HRs) and 95% CIs were estimated using multivariable Cox proportional hazard models for incident hypertension according to baseline PPI use (no/yes) and duration (3 years). The association between PPI use and 3‐year changes in measured blood pressure was examined using linear regression.
Results
There were 28 951 cases of incident hypertension after a mean follow‐up of 8.7 years. PPI use was associated with 17% higher risk of hypertension compared with nonuse in the fully adjusted model (HR, 1.17 [95% CI, 1.08–1.27]). Longer PPI use durations were significantly associated with incrementally higher risk of hypertension (HR, 1.13, 1.17, 1.28, respectively; trend P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Environmental Health University at Buffalo-SUNY Buffalo NY USA.
- School of Pharmacy University of Washington Seattle WA USA.
- Department of Family Medicine Warren Alpert Medical School of Brown University Pawtucket RI USA.
- College of Pharmacy The Ohio State University Columbus OH USA.
- College of Medicine Sulaiman AlRajhi University Bukariyah Saudi Arabia.
- University of Texas Medical Branch Galveston TX USA.
ORCID-Profile: Ahmed I Soliman, Jean Wactawski-Wende, Amy E Millen, Charles B Eaton, Kathleen M Hovey, Macarius Donneyong, Nazmus Saquib, Deepika Laddu, Simin Liu, Daichi Shimbo, Sylvia Wassertheil-Smoller, Michael J LaMonte
Förderung
- NHLBI NIH HHS
- WHI NIH HHS
Zitieren
APA
Soliman, A. I., Wactawski-Wende, J., Millen, A. E., Gray, S. L., Eaton, C. B., Hovey, K. M., Donneyong, M., Saquib, N., Mouton, C. P., Laddu, D., Liu, S., Shimbo, D., Wassertheil-Smoller, S., & LaMonte, M. J. (2025). Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040009
Vancouver
Soliman AI, Wactawski-Wende J, Millen AE, Gray SL, Eaton CB, Hovey KM, et al. Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.040009
BibTeX
@article{Soliman2025,
author = {Soliman, Ahmed I and Wactawski-Wende, Jean and Millen, Amy E and Gray, Shelly L and Eaton, Charles B and Hovey, Kathleen M and Donneyong, Macarius and Saquib, Nazmus and Mouton, Charles P and Laddu, Deepika and Liu, Simin and Shimbo, Daichi and Wassertheil-Smoller, Sylvia and LaMonte, Michael J},
title = {Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.040009}
}
EUVIMED